10 Oversold Biotech Stocks to Buy Now
Biotechnology stocks are among the most volatile in the market, primarily due to the high risks associated with their performance.
Arcellx Inc. (ACLX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Perceptive Advisors Joseph Edelman | 3,478,888 | $266,795,921 | -11% | 7.35% |
| 2. | RA Capital Management Peter Kolchinsky | 2,787,327 | $213,760,108 | +51% | 2.84% |
| 3. | SR One Capital Simeon George | 2,346,630 | $179,963,055 | 43.88% | |
| 4. | Cormorant Asset Management Bihua Chen | 1,300,000 | $99,697,000 | +4% | 5.47% |
| 5. | Vestal Point Capital Ryan Wilder | 475,000 | $36,427,750 | -30% | 2.15% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.00 | 312,500 | Large Shareholder | 6,745,262 | 2022-06-21 | Filing | |
| $15.00 | 1,600,000 | Large Shareholder | 2,033,196 | 2022-02-08 | Filing | |
| $15.00 | 66,667 | Large Shareholder | 3,466,811 | 2022-02-08 | Filing | |
| $15.00 | 1,583,333 | Large Shareholder | 6,432,762 | 2022-02-08 | Filing | |
| $15.00 | 1,600,000 | Director | 2,033,196 | 2022-02-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $62.69 | 10,889 | 149,186 | 2025-02-26 | Filing | ||
| $61.95 | 21,077 | 160,075 | 2025-02-26 | Filing | ||
| $61.14 | 6,334 | 181,152 | 2025-02-26 | Filing | ||
| $63.16 | 1,500 | 0 | 2025-02-25 | Filing | ||
| $64.88 | 208 | 37,486 | 2025-02-24 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,956,633 | $610,194,207 | 0.03% | |
| 2. | 6,720,803 | $515,418,382 | 33.22% | |
| 3. | 4,371,601 | $335,258,081 | 11.66% | |
| 4. | 3,854,021 | $295,564,873 | 0% | |
| 5. | 3,745,262 | $287,224,143 | 16.21% |
News See All
Is Arcellx (ACLX) Poised to Capture Significant Market Share?
Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2024 investor letter.
Arcellx (ACLX) Surged in Q3. Here’s Why
Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Here’s Why Arcellx (ACLX) Slipped in Q2
Baron Funds, an investment management company, released its “Baron Health Care Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Should You Be Bullish on Arcellx (ACLX)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here.
Insiders Are Dumping These 10 Healthcare Stocks
In this article, we will take a detailed look at Insiders Are Dumping These 10 Healthcare Stocks. For a quick overview of such stocks, read our article Insiders Are Dumping These 5 Healthcare Stocks...
25 Biggest Stocks with Negative Beta
Stock markets were in see-saw mode before the Fed’s September decision on rate hikes.
Should You be Bullish on Arcellx (ACLX)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here.
Billionaire Hedge Funds
